This article was originally published in The Gray Sheet
Executive SummaryIntroduces three wands for removing or shrinking tissue during arthroscopic joint surgery. The CoVac adds a suction feature to tissue removal and hemostasis and will allow surgeons to perform the procedure using a single instrument, the company says. The Saber, ArthoCare's first ArthroWand designed for cutting and removal of tissue along the entire length of the electrode, is expected to be used primarily for lateral release procedures in the knee and for releasing frozen shoulders. A third product, the Eliminator, has a broad brush-like design and larger electrode surface for "very rapid tissue removal and enhanced coagulation," and will be helpful in knee surgeries that involve reconstruction of the anterior cruciate ligament and sculpting of cartilage
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Genfit will delay unblinding of data from its nearly complete Phase III study of elafibranor to get insight from the FDA on statistical methods in order to optimize its NDA.
Revolution has just one drug in the clinic, but its focus on KRAS excited IPO investors. Also, Deciphera’s $175m offering leads recent follow-ons and Spruce raises $88m in venture capital.